PQE Group Reports Solid Year-End Results, Strengthens Position through Innovation in Pharmaceuticals and Medical Devices
27.1.2026 15:00:00 CET | Business Wire | Press release
Revenue gains, global expansion, industry recognition, and ESG leadership supported continued growth in 2025
2025 represented another successful year for PQE Group, a consulting firm in the Life Sciences industry based in Florence (Italy) that includes more than 2000 employees and 40+ offices worldwide. Recently named "Best Managed Company" by Deloitte Private for the sixth consecutive year, the Group achieved a rise in revenue, which reached € 105 millions in 2025, an increase of 7% compared to the €97,5M millions realized in 2024.
Founded by CEO Gilda D'Incerti in 1998, PQE Group is a women-owned company that has received numerous industry certifications, including ISO/IEC 27001, which is the world's best-known standard for information security, and ISO 9001, which focuses on quality management systems. To enhance its ongoing global expansion efforts, in 2025 PQE further expanded in the APAC Region, continued to strengthen its presence in North America, and established new offices in Latina, Italy and Copenhagen, Denmark. PQE also deepened its commitment to Artificial Intelligence (AI) in 2025, focusing heavily on PQE’s AI and Cybersecurity Services excellence and allocating significant resources to stay abreast of AI technological advancements, trends, and offerings in the Life Sciences industry.
In addition to receiving Deloitte Private’s Best Managed Company 2025 Award, PQE’s achievements and recognitions throughout the year included: Great Place to Work Certification for its US Subsidiary for the fourth consecutive year; Best Life Science Company in Maryland by Stellar Business Awards; Ecovadis Badge for Sustainability Excellence 2026; and recognition among the top 75 ESG performers at the Sustainability Award 2025, receiving the 2025 Sustainability Award Italy, which recognizes PQE’s commitment to ESG, the goals of which are published in its Sustainability Report each year, thereby disclosing detailed information on PQE’s sustainability strategy.
In 2025, PQE enhanced its already knowledgeable, professional SME staff by hiring additional senior level consultants and industry experts in numerous service areas, including the recent appointment of Francesco Minà as new Vice President Operations, who, after two decades spent working in the field of Automation and Operational Excellence for Johnson & Johnson, will now lead the service delivery of PQE Group at global level.
“2025 has been a positive year for PQE Group, a private company, made in Italy, with an international dimension,” said Gilda D’Incerti, PQE Group’s CEO & Founder. “This allows us to be in competition with the biggest consulting companies,” she continued, “and not only because of our global network and substantial number of highly specialized resources. By continuously monitoring industry trends and evolving technologies, we provide high-level solutions at competitive costs, pairing local responsiveness with global expertise, and we are quickly becoming one of the top worldwide consulting companies in the biopharmaceutical and medical device industries.”
As PQE continues to expand its global network, it is very committed to investing in expertise and knowledgeable professionals, delivering innovative and impactful solutions for its clients worldwide, and giving back through meaningful social responsibility initiatives— alongside an on-going commitment to patients’ safety and constant efforts to positively enhance the Life Science industry. On this note, the company is a proud member of the EU-funded Project-COMFORT Consortium that aims to transform healthcare through Patient Centric micro-Sampling (PCmS), a minimally invasive method for collecting and analyzing blood samples outside traditional clinical settings. For this effort, PQE is currently leading the “Work Package 7: Laying the Foundation for the Future”, to engage with the project’s audiences by sharing insights, updates, and outputs such as reports and publications.
About PQE Group
Established in Florence, Italy, in 1998, PQE Group is a woman-owned leading Life Science consulting firm, providing high-quality solutions in GCP, GLP, GMP, and GDP areas to both industry giants and small-mid-size businesses worldwide. With a focus on innovation, efficiency, and sustainability and with a global presence through its 40+ offices located around the world and 2000+ professional employees, PQE Group continues to set industry benchmarks and drive positive change in the Life Science sector. The Group's CEO & Founder, Gilda D'Incerti, has also launched ReSQ-UP, a groundbreaking initiative in the Clinical Research Organizations field, focusing on supporting emerging startups in women's health (FemTech), medical devices, and innovations in the biotech sector.
Visit us at PQE Group: Home - PQE Group , and follow PQE Group on LinkedIn, Instagram and Facebook
Learn more about Project-COMFORT: Home – Project-COMFORT, and follow us on LinkedIn
View source version on businesswire.com: https://www.businesswire.com/news/home/20260127299159/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Infopro Digital Automotive Highlights Its Industry-Leading Datasets at Automechanika 202626.8.2026 10:02:00 CEST | Press release
Infopro Digital Automotive, leader in data and software for the automotive market, announces its participation in Automechanika 2026, the world’s leading trade fair for the automotive industry. After completing several significant acquisitions over the past years, including Eucon, GiPA, and Aurelis last September, the company will attend this year’s trade show with a consolidated offering, built upon its trusted industry-leading datasets. Infopro Digital Automotive now addresses every automotive vertical from independent workshops to parts, tyres and car manufacturers, through the whole network of aftermarket distribution professionals, thus delivering to them key data and integrated digital solutions to power strategic decisions at every step of the vehicle lifecycle. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260826133342/en/ Infopro Digital Automotive’s unmatched dataset portfolio will be presented at Automechanika 20
NIPPON KINZOKU Establishes Mass Production of Ultra-Thin and Narrow Stainless Steel for Insulin Needles26.8.2026 10:01:00 CEST | Press release
- Addressing the Global Rise in Diabetes - NIPPON KINZOKU CO., LTD. (Headquarters: Minato-ku, Tokyo; President: Yasushi Shimokawa; TOKYO: 5491) is pleased to announce the commencement of mass production for its "Ultra-thin and narrow-width stainless steel" optimized for laser welding in ultra-fine insulin needles. In response to growing global demand, the company has established a stable supply system for these high-quality materials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260826770424/en/ The scale of the global diabetes crisis is expanding. In line with this trend, the global demand for insulin needles continues to escalate. Furthermore, insulin delivery is evolving toward "painless" experiences that reduce patient burden. Modern designs prioritize minimizing pain and bruising, leading to the widespread adoption of ultra-fine needles. This trend is further supported by the growing popularity of compact, portable pe
VirTus Respiratory Research Supports Development of Apollo Therapeutics’ APL-10456 from Preclinical Proof of Concept to Positive Phase 1 Data26.8.2026 10:00:00 CEST | Press release
VirTus Respiratory Research Ltd, a specialist respiratory contract research organisation (CRO), founded by Imperial College London investigators Professor Sebastian Johnston and Dr Michael Edwards, today highlighted its role in the preclinical development of Apollo Therapeutics’ and Imperial’s APL-10456, following the announcement of positive initial data from the vaccine’s Phase 1 clinical trial. VirTus has worked on the APL-10456 programme for more than five years, conducting more than 20 preclinical studies to support the selection, development and progression of the candidate, testing the cross-species immunogenicity and efficacy. This work included evaluating the efficacy of several vaccine candidates in mouse models of rhinovirus infection, helping to select APL-10456 and establish early proof of concept and generating preclinical evidence that informed its progression into first-in-human clinical development. APL-10456 is a first-in-class, adjuvanted recombinant protein subunit
Xsolla President Chris Hewish Debuts “Durable Advantage” at Gamescom 202626.8.2026 09:00:00 CEST | Press release
Book Draws on Chris Hewish’s Three Decades of Leadership in the Global Games Industry, Grounded in “Renters vs. Owners” Theory and Five-Pillars for Scaling and Succeeding Xsolla, a leading global commerce company, today announced Durable Advantage: Five Pillars of the Modern Game Business, a new book authored by Chris Hewish, President of Xsolla, launching at Gamescom 2026 in Cologne. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260826628682/en/ Graphic: Xsolla Xsolla's integrated strategy brings together global payments, direct-to-consumer commerce, backend infrastructure, and AI-powered development tools into a unified operating model designed to help studios launch, operate, and scale more efficiently. Rather than relying on disconnected commerce, engagement, and backend systems, developers can activate new capabilities through a common platform foundation that reduces complexity, accelerates deployment, and creates a m
David Hagan, Dean and Pegasus Professor at CREOL, The College of Optics and Photonics, Will Serve as Vice President of SPIE26.8.2026 05:00:00 CEST | Press release
Newly elected SPIE board members bring distinct backgrounds to optics and photonics community David Hagan has been elected to serve as the 2027 Vice President of SPIE, the international society for optics and photonics. He will serve as President-Elect in 2028, and as the Society’s President in 2029. The SPIE Board of Directors is influential in the scientific community, establishing policy and strategy and conducting activities of interest to SPIE Members. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260825934622/en/ Top row, from left to right: David Hagan, Jim McNally, Mark Clampin. Bottom row, from left to right: Marla Dowell, Jana Kainerstorfer, Katie Schwertz The 2026 SPIE President, Julie Bentley, professor of optics at the University of Rochester, made the new electees announcement at the Annual General Meeting of the Society on 25 August during SPIE Optics + Photonics. Terms begin on 1 January 2027. In addition to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom